Home»Latest 30days News on Medical, Biotech/Pharma - weSRCH
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech:-Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine:-Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech:-Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business:-Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1145 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
    Bristol-Myers Squibb expands manufacturing agreement with Lonza - Pharmaceutical Business Review
      Pharmaceutical Business Review Lonza COO of Pharma & Biotech Segment Marc Funk said: "We are pleased to extend our relationship with Bristol-Myers Squibb for the commercial production of their innov ....more | Save |  Share  Email 31st Oct 2014 
    GlaxoSmithKline introduces Incruse Ellipta in UK for COPD patients - Pharmaceutical Business Review
      Production & Manufacturing > Manufacturing > Suppliers Alpex Pharma - High Quality Formulation Development & Manufacturing Company Alpex Pharma is a pharmaceutical company active in Researc ....more | Save |  Share  Email 31st Oct 2014 
    NewLeaf sees the future of biotech, and it's pink - STLtoday.com
      Local boosters talk a lot these days about the region's potential as a biotech center. What do you see as the advantages and disadvantages of having your company based in the St. Louis area? We chose St. Louis specifically as a hu ....more | Save |  Share  Email 30th Oct 2014 
    Retirees Feeling Anxious? Take 3 Of These Pharmaceuticals, Then Call Me In ... - Seeking Alpha (registration)
      Seeking Alpha (registration) This capitulation after a 9.6% near-correction was another in a series of opportunity entry points for dividend growth investors. All this turmoil has given me a hea ....more | Save |  Share  Email 30th Oct 2014 
    Comedian J. Anthony Brown to return to Muskegon for annual diabetes conference - Muskegon Chronicle
      JAnthonyBrown.jpg Comedian and actor J. Anthony Brown of the Tom Joyner and the Rickey Smiley morning radio programs will be the featured speaker at the 11th Annual diabetes health conference in Muskegon ....more | Save |  Share  Email 30th Oct 2014 
    Purple Book Launches New Chapter in Generic Drugs - Connecticut Law Tribune
      Connecticut Law Tribune Biologics, namely biologically derived therapeutic agents such as viruses, vaccines, blood products and nonsynthetic proteins, account for a large and growing portion of total spending on prescription med ....more | Save |  Share  Email 30th Oct 2014 
    Qualitas Enters Distribution Agreement With Lipa Pharmaceuticals - Natural Products INSIDER
      IMPERIAL, Texas-Qualitas Health finalized an exclusive distribution agreement with Lipa Pharmaceuticals for its Almega PL omega-3 ingredient for sale to the dietary supplement industry in Australia and New Zeala ....more | Save |  Share  Email 30th Oct 2014 
    Top Diabetes Prospect Scott MacLean, 6, Excited for 2014 Halloween Season - Huffington Post (satire)
      JACKSON - With the 2014 Halloween season only a day away, all eyes are on 6-year-old and top type II diabetes prospect Scott MacLean, of Jackson, Mississippi. MacLean, nicknamed "Mr. October" ....more | Save |  Share  Email 30th Oct 2014 
    Unlikely Marriage Of Diseases: TB And Diabetes Form A 'Co-Epidemic' - NPR (blog)
      NPR (blog) The world is facing a double-barreled pandemic reminiscent of the dual epidemic of tuberculosis and HIV that emerged in the 1980s - only potentially much bigger. It's a "co-epidemic" of TB a ....more | Save |  Share  Email 30th Oct 2014 
    West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More - Xconomy
      -Although biotech IPOs are no longer arriving at the breakneck pace we saw earlier this year, San Francisco's Fibrogen set terms for a Nasdaq debut that could give the biotech a $1 billion market cap. It is aiming to ....more | Save |  Share  Email 30th Oct 2014 
    The state's biotech community mourns the passing of former Boston Mayor Tom ... - Boston Business Journal (blog)
      Boston Business Journal (blog) Vertex Pharmaceuticals officially celebrated the opening of its new headquarters on Fan Pier in February, a site the 25-year-old biotech was lured to from C ....more | Save |  Share  Email 30th Oct 2014 
    376 new jobs promised after Chinese company chooses to open plant in ... - wtvr.com
      wtvr.com PETERSBURG, Va. - The governor announced more than 370 jobs would be coming to Petersburg after UniTao Pharmaceuticals LLC purchased the Boehringer Ingelheim plant with plans to invest $22.5 million t ....more | Save |  Share  Email 30th Oct 2014 
    Paratek Pharmaceuticals Completes Merger With Transcept Pharmaceuticals - GlobeNewswire (press release)
      BOSTON, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) and Transcept Pharmaceuticals, Inc. (Nasdaq:TSPT) (through October 30) today announced the two companies have com ....more | Save |  Share  Email 30th Oct 2014 
    Tonix Pharmaceuticals: Phase II, Phase III, And Beyond For TNX-102 (TNXP) - Seeking Alpha (registration)
      Tonix Pharmaceuticals Holding Corporation (NASDAQ:TNXP) is a development-stage pharmaceutical company working to treat difficult central nervous system disorders. Currently the company is focused on ....more | Save |  Share  Email 30th Oct 2014 
    Show Transcript Hide Transcript - WMUR Manchester
    Aspen - Today's stocks pick within the Pharmaceuticals sector - CNBCAfrica.com
      Aspen is now a significant global pharma company, supplying branded and generic pharmaceuticals in more than 150 countries across the world. It was founded by Stephen Saad less than 15 years ago. Aspen has a market cap o ....more | Save |  Share  Email 30th Oct 2014 
    Cannabis-Based Pharmaceuticals: The Next Frontier? - Life Science Leader Magazine
      Life Science Leader Magazine While the business case for developing pharmaceutical cannabis-based drugs is sound, the cost and time required for regulatory approval of these products will be much greater than those require ....more | Save |  Share  Email 30th Oct 2014 
    Moms, Regulators, Biotech Startups, and the Battle Over a Potentially Life ... - Businessweek
      Businessweek Three small biotech companies are competing to develop drugs designed to address the cellular defects that cause some cases of Duchenne. If proven safe and effective, the drugs would turn Duchenne ....more | Save |  Share  Email 30th Oct 2014 
    China-based company buys Petersburg chemical plant, plans 376 jobs - Richmond Times-Dispatch
      Richmond Times-Dispatch A China-based pharmaceutical company has purchased the Boehringer Ingelheim plant in Petersburg and plans 376 jobs, Gov. Terry McAuliffe announced Thursday morning. UniTao Pharmaceuticals ....more | Save |  Share  Email 30th Oct 2014 
    Healthcare Transformation and the Price of Pharmaceuticals - AJMC.com Managed Markets Network
      Experts opened the 64th Annual Roy A. Bowers Pharmaceutical Conference: A Measured Approach-Health Care Delivery and Transformation in a Metric Driven World, held by the Ernest Mario School of Pharmacy at Rutg ....more | Save |  Share  Email 30th Oct 2014 
    Total record(s) 1145 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>